Do diabetes shots help knee arthritis in heavy people?
Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
Weight loss explained only 32.1% of the reduced surgery risk
Most assumed the benefit of GLP-1 drugs on joints was purely from weight loss, but over two-thirds of the protective effect comes from other mechanisms—possibly anti-inflammatory or metabolic effects.
Practical Takeaways
If you have type 2 diabetes and knee arthritis, talk to your doctor about GLP-1 drugs—not just for blood sugar, but for joint health.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
Weight loss explained only 32.1% of the reduced surgery risk
Most assumed the benefit of GLP-1 drugs on joints was purely from weight loss, but over two-thirds of the protective effect comes from other mechanisms—possibly anti-inflammatory or metabolic effects.
Practical Takeaways
If you have type 2 diabetes and knee arthritis, talk to your doctor about GLP-1 drugs—not just for blood sugar, but for joint health.
Publication
Journal
Annals of the Rheumatic Diseases
Year
2023
Authors
Hongyi Zhu, Lenian Zhou, Qiuke Wang, Qianying Cai, Fan Yang, Hanqiang Jin, Yiwei Chen, Yanyan Song, Changqing Zhang
Related Content
Claims (5)
For adults with knee pain from arthritis and type 2 diabetes, taking GLP-1 drugs like Ozempic may slightly reduce pain based on a scoring system, but the change is probably too small for people to actually notice in their daily lives.
People with knee arthritis and type 2 diabetes who take GLP-1 drugs like Ozempic might lose knee cartilage more slowly, which could help delay joint damage.
People with knee arthritis and type 2 diabetes who take GLP-1 drugs like semaglutide tend to lose a lot more weight—about 7 extra kilograms—over nearly 8 years compared to those not taking them, and many more of them achieve meaningful weight loss.
People with knee arthritis and type 2 diabetes who take GLP-1 drugs (like Ozempic) may be less likely to need knee surgery—only 1.7% did, compared to 5.9% who didn’t take the drugs, over about 8 years.
For people with knee arthritis and type 2 diabetes, taking GLP-1 drugs (like Ozempic) may lower the chance of needing knee surgery — and about one-third of that benefit comes from losing weight, not just from better blood sugar control.